The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
about
Genetic susceptibility to occupational exposuresInteraction of occupational and personal risk factors in workforce health and safetyN-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 geneDistinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.Nephrotoxicity and nephrocarcinogenicity of dinitrotoluene: new aspects to be considered.The role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease.Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology.Toxicological assessment of noxious inhalants.SNPs in cancer research and treatment.Impact of urinary bladder cancer risk variants on prognosis and survival.The post GWAS era: strategies to identify gene-gene and gene-environment interactions in urinary bladder cancer.Arylamine N-acetyltransferases: what we learn from genes and genomes.Genetic association studies in cancer: good, bad or no longer ugly?Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese populationThe debate on carcinogenicity of permanent hair dyes: new insights.Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany.Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.Occupational risk factors for relapse-free survival in bladder cancer patients.N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany.Glutathione S-transferase P1 ILE105Val polymorphism in occupationally exposed bladder cancer cases.N-acetyltransferase 1*10 genotype in bladder cancer patients.Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators.Effect of CYP3A4 genetic polymorphisms on the genotoxicity of 4,4'-methylene-bis(2-chloroaniline)-exposed workers.Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.Genetic variants confer susceptibility to urinary bladder cancer: an updated list of confirmed polymorphisms.Bladder cancer and occupational exposures in North Rhine-Westphalia, Germany.Isoniazid acetylation phenotyping in Saudi Arabs.Arylalkylamine N-acetyltransferase (AANAT) genotype as a personal trait in melatonin synthesis.Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies.Algorithm for the Automated Evaluation of NAT2 Genotypes.Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.The ultra-slow NAT2*6A haplotype is associated with reduced higher cognitive functions in an elderly study group.Bladder cancer in crack testers applying azo dye-based sprays to metal bodies.N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism in bladder cancer cases.
P2860
Q23911384-5D8B2606-2DE2-4DCA-AA25-AA2F6FE980A4Q23919248-505EFF32-025D-4C94-A95A-2890916B0C33Q28388128-374D8C4C-B1A4-4AA8-9BD1-F350CD541EC2Q28506641-1A4C14AE-A71F-45DC-8ED1-548241F90CB8Q34532463-F12F8DA1-19CB-496F-A90C-F4FE75F79AC5Q35014786-A1A7AA4C-EF2A-4C24-9BCC-B8864EB1943DQ35038737-5F688C8C-713A-496D-AD21-F621F914C5EAQ35162366-E6AFCA72-000E-47EF-A83C-349BF2FF8D43Q35427224-7324EEB1-7C1B-4F03-8556-75DD01F7E27BQ35670196-EBF0D72D-1C7D-4FA8-A85D-2440D6B6E726Q35717096-49B3B76B-F87D-4599-AB3E-7517020E65F6Q35729161-9E5290EB-6C2E-4CEC-ABDE-6D1DD12C2B8BQ36300809-867BFBAB-59DD-4C63-A03A-522ED698AB1EQ36474994-81156377-BE0A-4892-AAC1-3151A587F018Q36662484-82C2AA14-4537-4E3B-97A9-619C650C3ADAQ36895434-4BCEC2F6-9CD7-41A9-9B34-ED03387CA7C6Q37457764-CB76879E-E6EC-4878-B33C-F06F60151864Q38399978-F2C0B3E4-B412-4606-A39C-25F785137166Q38399984-AAC38E31-731D-4168-8EEC-F3C3CC9746BDQ38404020-ED85EECE-6DFE-43F8-BD26-0377493B82D6Q38455624-1D80E0A3-F51C-4B5C-B0B7-1351656E87AEQ38455630-74EEA5C7-E209-4251-B601-FA0E60C0F6EAQ38684208-A0C55C8E-EE4A-4350-8157-6349D762C503Q38684214-95B7A609-4B58-438A-B49D-514ABC2F502EQ39336687-185A0138-B6AA-47B4-BA71-149176F7CC88Q40563049-A440BB2F-18EA-4BEE-8230-8E8530E51AB5Q42708451-CDF15357-FAAC-48E2-9616-D8BBA4E6FAF5Q42769306-AE500323-488C-45B5-A523-7E7C1C1D0335Q44426994-6189DE5C-5552-4612-A656-E20193CE1B24Q45105243-E3A1DAF1-84F1-4275-AE7F-A6F3CE94C318Q46527386-27690073-81E4-49C0-A7F3-212FC02C371BQ47113559-D4698710-03BF-45D0-ACB9-2CED905EBB01Q47692734-BED776EE-2B3A-4CA2-AE70-ED60EE4269E2Q48123467-5C51A6B5-F359-4555-BA21-D9C8B5115116Q50317492-E52664D1-8B24-4DD5-883A-6506CAA578A2Q50509306-E92178B0-FC93-4B09-8CA2-6AB98D9C2DA9Q54185930-8AF9F00B-4AF5-4725-BF52-72A860D495AFQ54527775-FA0B4923-531A-4093-8940-32E2513759D4
P2860
The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The enhanced bladder cancer su ...... onsidering ethnic differences.
@ast
The enhanced bladder cancer su ...... onsidering ethnic differences.
@en
The enhanced bladder cancer su ...... onsidering ethnic differences.
@nl
type
label
The enhanced bladder cancer su ...... onsidering ethnic differences.
@ast
The enhanced bladder cancer su ...... onsidering ethnic differences.
@en
The enhanced bladder cancer su ...... onsidering ethnic differences.
@nl
prefLabel
The enhanced bladder cancer su ...... onsidering ethnic differences.
@ast
The enhanced bladder cancer su ...... onsidering ethnic differences.
@en
The enhanced bladder cancer su ...... onsidering ethnic differences.
@nl
P2093
P1433
P1476
The enhanced bladder cancer su ...... onsidering ethnic differences.
@en
P2093
Hermann M Bolt
Klaus Golka
Meinolf Blaszkewicz
Verena Prior
P304
P356
10.1016/S0378-4274(01)00544-6
P577
2002-03-01T00:00:00Z